Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
about
Severe refractory autoimmune hemolytic anemia with both warm and cold autoantibodies that responded completely to a single cycle of rituximab: a case reportB2 cells suppress experimental abdominal aortic aneurysms.Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysisA case of Evans syndrome combined with systemic lupus erythematosus successfully treated with rituximab.A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia.Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients.Stem cell transplantation for patients with Evans syndrome.Autoimmune complications in chronic lymphocytic leukaemia (CLL).Immune thrombocytopenia: no longer 'idiopathic'.Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.A New Kid on the Block: IL-10+ Regulatory B Cells and a Possible Role In Psoriasis.Successful treatment of refractory idiopathic thrombocytopenic purpura and neutropenia with the monoclonal antibody, rituximabRefractory autoimmune hemolytic anemia in a patient with DiGeorge syndrome treated successfully with plasma exchange: a case report and review of the literature.Barriers to the Access and Use of Rituximab in Patients with Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia: A Physician Survey.Use of rituximab in autoimmune hemolytic anemia associated with non-hodgkin lymphomasEmergence of targeted immune therapies for systemic lupus.The Effect of Histological CD20-Positive B Cell Infiltration in Acute Cellular Rejection on Kidney Transplant Allograft Survival.Autoimmune hemolytic anemia: classification and therapeutic approaches.Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders.Classification and therapeutic approaches in autoimmune hemolytic anemia: an update.Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis.Rituximab: current status as therapy for malignant and benign hematologic disorders.Current approaches for the treatment of autoimmune hemolytic anemia.Immunotherapy treatments of warm autoimmune hemolytic anemia.Severe refractory autoimmune hemolytic anemia with five-year complete hematologic response to third course of treatment with rituximab: a case report.Radioimmunotherapy of non-Hodgkin's lymphoma: a critical appraisal.Resolution of alloimmunization and refractory autoimmune hemolytic anemia in a multi-transfused beta-thalassemia major patient.A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia.Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia.Evans syndrome: clinical perspectives, biological insights and treatment modalities
P2860
Q21202088-CD76DBF8-42EF-47D2-A226-1CA4357EADC4Q30370021-7887666D-E653-4DFE-A678-799848822791Q33376705-9021B814-44D8-4D66-9EF8-63857AF8712DQ33380257-8DF3737F-E0B1-4919-887F-4451A098B6B4Q33384219-739C7B52-CDE6-416F-839C-C1DB1E308002Q33387348-85D313A9-ED1A-4CFC-8B41-3526024A0C74Q33389601-812BE7F7-0B1B-48E1-B8DE-ECFF27F06664Q33390656-E1FF81DF-8737-4A34-A789-7E6F8C0D31BAQ33395624-1624D5B6-C63F-43E6-B122-8F9AF22DEBA0Q33401100-7E629F76-7E2D-4E09-82CD-BFE09AE58D62Q33403761-F6A904EC-5440-468F-93B6-0C9A445FC571Q33408154-CE0B8E80-2214-487A-BE76-A549778895F3Q33416827-E80975F6-2D0B-40D2-9E00-38392F279123Q33673144-9CFD649C-4F34-411F-8BED-14992C7C8D3AQ34922723-CD5EE3AA-F15F-49DE-9B8B-22AE68E45864Q36066014-B9D1F54C-04D0-4D82-8602-97FC0B03CF79Q37531824-F62B7793-4029-4F18-890F-B9065D743E0BQ37810065-15A57C46-4D82-4BFD-9811-B595BFC75741Q37843939-6FBA5734-624F-463A-8C0E-9A88298684B8Q37955228-AE77385E-F123-49D5-BFCF-4D8C3B197D37Q37968620-4FB713CD-3087-4B00-9926-3DF6FDEE7F6FQ37984551-4EA6E693-031A-403A-A9C3-004B52D532DBQ38108152-71339849-64BD-4464-AD82-764FDC7949D3Q38150845-B8873C64-59B0-4305-B90F-A145028955DBQ39182043-602F30DE-B599-4A19-AD54-E785B4D334CBQ40426685-C680AA6E-AC72-4FF8-86CC-5F495902CC47Q42028283-FD9D5541-DDE3-4835-A3E2-2CBF8B254CB5Q47690234-D02C0534-BD3F-49BF-9D57-A1D07B4CA06AQ48335821-B86534E7-DE32-43EF-85A4-BE90C27D27D5Q57816250-BD7A723B-B5A7-4332-8D9C-2C899CA940F9
P2860
Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Rituximab for immune cytopenia ...... ic anemia, and Evans syndrome.
@ast
Rituximab for immune cytopenia ...... ic anemia, and Evans syndrome.
@en
type
label
Rituximab for immune cytopenia ...... ic anemia, and Evans syndrome.
@ast
Rituximab for immune cytopenia ...... ic anemia, and Evans syndrome.
@en
prefLabel
Rituximab for immune cytopenia ...... ic anemia, and Evans syndrome.
@ast
Rituximab for immune cytopenia ...... ic anemia, and Evans syndrome.
@en
P2093
P356
P1476
Rituximab for immune cytopenia ...... ic anemia, and Evans syndrome.
@en
P2093
Hans L Madueme
Robert C Wolf
Tait D Shanafelt
P304
P356
10.4065/78.11.1340
P407
P577
2003-11-01T00:00:00Z